ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
The Pharmaceutical Company Licenses in Two New Drugs for Dry Eye Disease with over 200 Million US Dollars
August 25, 2021On August 5, Oyster Point Pharma, Inc. revealed on its official website that it has reached a cooperation agreement with Ji Xing Pharmaceuticals, which will develop and commercialize OC-01 (varenicline) and OC-02 (simpinicline) nasal sprays for patients.
Pharma Sources Insight January 2025
